Top Links

Articles Related to Pharmacology

Veterinary Considerations for the Theoretical Resurrection of Extinct Species

The de-extinction of the dinosaur is a dubious possibility but its consideration brings forth some issues that are at least worthy of scientific discussion. In this review, we discuss two distinct issues that have implications for a de-extinct species such as a dinosaur: the ability, or lack thereof, to safely sedate a rare and potentially fractious animal capable of harming the veterinary staff tasked with its care; and, disease risks associated with a species that has been extinct for millions of years. To identify potential sedatives, comparative pharmacology will be needed to uncover the links between receptor pharmacology and the desired clinical outcomes of activating established alpha-2 adrenergic, opioid, and benzodiazepine receptors. Specific to disease control, it will be necessary to understand the unique susceptibility of the new species to current diseases as well as predicting their reservoir capacity for potential human and veterinary pandemic diseases. While the topics presented herein are not exhaustive, this review highlights some of the foremost research that should be conducted in order to serve the unique veterinary needs of a de-extinct species using the dinosaur as a paradigm. Addressing these issues should be considered if an intact dinosaur genome becomes available, regardless of the feasibility of dinosaur resurrection.
View complete article: PDF  |  Full-text

Pharmacy Compounding Quality Control and Pharmaceutical Development Strategies for Seventeen alpha Hydroxyprogesterone Caproate in Prevention of Preterm Delivery

Seventeen alpha hydroxyprogesterone caproate (17-OHPC) is the only FDA-approved drug labeled for prevention of preterm delivery. This drug is also available as a compounded product from licensed compounding pharmacies. This article reviews the FDA approval history and pharmacy compounding quality control data of 17-OHPC, as well as briefly discusses possible future pharmaceutical development strategies for 17-OHPC.
View complete article: PDF  |  Full-text

Treatments for Atopic Dermatitis

Atopic dermatitis, also known as eczema, affects about 10-20% of children in the UK and about 1-3% of adults [1]. The incidence of atopic dermatitis has increased as much as 3 fold in the past 40 years
View complete article: PDF  |  Full-text  | Digital
 
 


Editorial Board Members Related to Pharmacology

CODY P. COYNE

Professor
Department of Basic Science
Mississippi State University
United States

Yanyan Li

Assistant Professor
Department of Health and Nutrition Sciences
Montclair State University
United States

Mohamed Eddouks

Professor
Faculty of Sciences and Techniques Errachidia
Moulay Ismail University
Morocco

P. S. SURESH

Assistant Professor
Department of Bio-Sciences
Mangalore University
India

Sue Hudson Duran

Professor
Auburn University
United States

Kiminobu Sugaya

Professor
Burnett School of Biomedical Sciences
College of Medicine
University of Central Florida
United States

EUGENE A. CIOFFI

Associate Professor
Department of Pharmacology
College of Medicine
University of South Alabama
United States

Alex Bekker

Professor and Chair, Department of Anesthesiology
Professor, Department of Physiology and Pharmacology
Rutgers New Jersey Medical School
United States

Hsien-Yuan Lane

Professor
Director and Professor
Department of Psychiatry
China Medical University Hospital.

Hong Zhu

Associate Professor
Campbell University School of Osteopathic Medicine
United States
Submit Manuscript